| Product Code: ETC13337963 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Influenza Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Influenza Vaccines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Influenza Vaccines Market - Industry Life Cycle |
3.4 Europe Influenza Vaccines Market - Porter's Five Forces |
3.5 Europe Influenza Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Europe Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.8 Europe Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Europe Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Europe Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Influenza Vaccines Market Trends |
6 Europe Influenza Vaccines Market, 2021 - 2031 |
6.1 Europe Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Influenza Vaccines Market, Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031 |
6.1.3 Europe Influenza Vaccines Market, Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031 |
6.1.4 Europe Influenza Vaccines Market, Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031 |
6.2 Europe Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Influenza Vaccines Market, Revenues & Volume, By Trivalent Vaccines, 2021 - 2031 |
6.2.3 Europe Influenza Vaccines Market, Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031 |
6.3 Europe Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Influenza Vaccines Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.3.3 Europe Influenza Vaccines Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.3.4 Europe Influenza Vaccines Market, Revenues & Volume, By Geriatric, 2021 - 2031 |
6.4 Europe Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Influenza Vaccines Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.4.3 Europe Influenza Vaccines Market, Revenues & Volume, By Nasal Spray, 2021 - 2031 |
7 Europe Influenza Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Germany Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 France Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Poland Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.5 Spain Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.6 Rest of Europe Influenza Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Europe Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.2 Germany Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.3 France Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.4 Poland Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.5 Spain Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.3.6 Rest of Europe Influenza Vaccines Market, Revenues & Volume, By Strain Type, 2021 - 2031 |
7.4 Europe Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 United Kingdom (UK) Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 Germany Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 France Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Poland Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.5 Spain Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.6 Rest of Europe Influenza Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Europe Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 United Kingdom (UK) Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Germany Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 France Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Poland Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.5 Spain Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.6 Rest of Europe Influenza Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8 Europe Influenza Vaccines Market Key Performance Indicators |
9 Europe Influenza Vaccines Market - Export/Import By Countries Assessment |
10 Europe Influenza Vaccines Market - Opportunity Assessment |
10.1 Europe Influenza Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Europe Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
10.4 Europe Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Europe Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
11 Europe Influenza Vaccines Market - Competitive Landscape |
11.1 Europe Influenza Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Europe Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here